<DOC>
	<DOCNO>NCT01986712</DOCNO>
	<brief_summary>To evaluate compliance perception treatment , well health-related quality life ( HRQOL ) surgically resect melanoma patient undergo HDI PEG IFN therapy .</brief_summary>
	<brief_title>A Study Compare Quality Life Compliance Patients Receiving High-dose Interferon Versus Pegylated Interferon Patients With Surgically Resected Melanoma</brief_title>
	<detailed_description>The primary objective study : â€¢ To evaluate compliance administration standard HDI versus PEG IFN patient melanoma need adjuvant therapy The secondary objective study : - To compare convenience satisfaction chemotherapy patient standard HDI versus PEG IFN use chemotherapy convenience satisfaction questionnaire ( CCSQ ) evaluate treatment-related side effect may impact patient 's HRQOL use Functional Assessment Cancer Therapy Biologic Response Modifier ( FACT BRM ) - To assess frequency Grade 3 4 toxicity , accord National Cancer Institute ( NCI ) Common Toxicity Criteria Adverse Events ( CTCAE ) patient standard HDI versus PEG IFN - To examine reason patient ' choice treatment HDI versus PEG IFN , case patient presented choice either treatment option - To assess Health Resource Utilization arm study</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<criteria>Patient male female least 18 year age Patient surgically resect melanoma plan receive adjuvant therapy HDI PEG IFN Patient willing able give write informed consent Patient willing comply study requirement Patient unable unwilling complete QoL questionaire compliance diary Patient history anaphylaxis due interferon alpha product Patient autoimmune hepatitis Patient decompensated liver disease ( ChildPugh score &gt; 6 ( Class B C ) Patient history neuropsychiatric disorder ( include depression ) , judgment investigator , may impair patient 's ability successfully complete treatment protocolrelated requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>